Inhibition of prostaglandins does not reduce the cardiovascular changes during endotoxemia in rats

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 74, Issue 2, 2006, Pages 135-142

  Azab, Abed ^a,b   Kobal, Sergio ^b   Rubin, Mazal ^a   Kaplanski, Jacob ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ESCHERICHIA COLI LIPOPOLYSACCHARIDE; INDOMETACIN; INTERLEUKIN 1BETA; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY TEMPERATURE; BRAIN LEVEL; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DRUG EFFECT; ECHOCARDIOGRAPHY; ENDOTOXEMIA; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART PROTECTION; HEART RATE; HYPOTHERMIA; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN BLOOD LEVEL; PROSTAGLANDIN SYNTHESIS INHIBITION; PROTEIN BLOOD LEVEL; RAT;

ANIMALS; BODY TEMPERATURE; DIMETHYL SULFOXIDE; DINOPROSTONE; ENDOTOXEMIA; HEART RATE; HYPOTHALAMUS; HYPOTHERMIA; INDOMETHACIN; INTERLEUKIN-1; MALE; RATS; RATS, SPRAGUE-DAWLEY; TUMOR NECROSIS FACTOR-ALPHA; VENTRICULAR DYSFUNCTION, LEFT;

ANIMALIA; ESCHERICHIA COLI;

EID: 30544436874     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2005.10.004     Document Type: Article

References (43)

1. S. Sriskandan, and J. Cohen The pathogenesis of sepsis J. Infect. 30 1995 201 206
2. M.J. Kluger Fever: role of pyrogens and cryogens Physiol. Rev. 71 1991 93 127
3. J. Gauldie, J. Lamontagne, and A. Stadnyk Acute phase response in infectious disease Surv. Synth. Pathol. Res. 4 1985 126 156
4. L.E. Morrow, J.L. McClellan, C.A. Conn, and J.M. Kluger Glucocorticoids alter fever and IL-6 responses to physiological stress and to lipopolysaccharide Am. J. Physiol. 264 1993 1010 1016
5. T. Vander Poll, H.R. Buller, and H.T. Ten Cate Activation of coagulation after administration of TNF to normal subjects N. Engl. J. Med. 322 1990 1622 1627
6. J.H. Pruitt, E.M. Copeland, and L.L. Modawer Interleukin-1 and interleukin-1 antagonism in sepsis, systemic inflammatory response syndrome, and septic shock Shock 3 1995 235 251
7. T. Vander Poll, and S.F. Lowry Tumor necrosis factor in sepsis: mediator of multiple organ failure or essential part of host defense Shock 3 1995 1 12
8. B. Chernow, T.G. Rainey, and C.R. Lake Endogenous and exogenous catecholamine in critical care medicine Crit. Care Med. 10 1982 409 416
9. S.M. Hollenberg, J.J. Tangora, M.J. Piotrowski, C. Easington, and J.E. Parrillo Impaired microvascular vasoconstrictive responses to vasopressin in septic rats Crit. Care Med. 25 1997 869 873
10. J.L. Masferrer, B.S. Zweifel, K. Seibert, and P. Needleman Selective regulation of cellular cyclooxygenase by dexamethasone and endotoxin in mice J. Clin. Invest. 86 1990 1375 1379
11. G. Feuerstein, and J.M. Hallenbeck Prostaglandins, leukotrienes, and platelet-activating factor in shock Ann. Rev. Pharmacol. Toxicol. 27 1987 301 313
12. B. Beutler, and V. Krugs Lipopolysaccharide signal transduction, regulation of tumor necrosis factor biosynthesis, and signaling by tumor necrosis factor itself J. Cardiovasc. Pharmacol. 25 1995 1 8
13. K. Hocherl, F. Dreher, A. Kurtz, and M. Bucher Cyclooxygenase-2 inhibition attenuates lipopolysaccharide-induced cardiovascular failure Hypertension 40 2002 947 953
14. M. Leach, L.C. Hamilton, A. Olbrich, G.M. Wray, and C. Thiemermann Effects of inhibitors of the activity of cyclooxygenase-2 on the hypotension and multiple organ dysfunction caused by endotoxin - a comparison with dexamethasone Br. J. Pharmacol. 124 1998 586 592
15. J.L. Wallace Selective COX-2 inhibitors: is the water becomes muddy TiPS 20 1999 4 6
16. H. Ruetten, and C. Thiemermann Combination immunotherapy which neutralizes the effect of TNF alpha and IL-1 beta attenuates the circulatory failure and multiple organ dysfunction caused by endotoxemia in the rat J. Physiol. Pharmacol. 48 1997 605 621
17. S. Kapadia, J. Lee, G. Torre-Amione, H.H. Birdsall, T.S. Ma, and D.L. Mann Tumor necrosis factor alpha gene and protein expression in adult feline myocardium after endotoxin administration J. Clin. Invest. 96 1995 1042 1052
18. J. Parker, and H.R. Adams Development of myocardial dysfunction in endotoxin shock Am. J. Physiol. 248 1985 818 826
19. L. Paul, V. Fraifeld, and J. Kaplanski Evidence supporting involvement of leukotrienes in LPS-induced hypothermia in mice Am. J. Phsiol. 276 1999 52 58
20. A.N. Azab, and J. Kaplanski Vagotomy attenuates the effect of lipopolysaccharide on body temperature of rats in a dos-dependent manner J. Endotoxin Res. 7 2001 359 364
21. A.N. Azab, V. Fraifeld, and J. Kaplanski Nimesulide prevents lipopolysaccharide induced elevation in plasma tumor necrosis factor α in rats Life Sci. 63 1998 323 327
22. A.N. Azab, S. Kobal, M. Rubin, and J. Kaplanski Effects of nimesulide, a selective cyclooxygenase-2 inhibitor, on cardiovascular alterations in endotoxemia Cardiology 103 2005 92 100
23. T.T. Pizzaro, K. Malinowska, E.J. Kovocs, J. Clancy, J.A. Robinson, and L.A. Piccinini Induction of TNF α and TNF β gene expression in rat cardiac transplants during allograft rejection Transplantation 56 1993 399 404
24. G. Torre-Amione, S. Kapadia, J. Lee, J.B. Durand, R.D. Bies, J.B. Young, and D.L. Mann Tumor necrosis factor α and tumor necrosis factor receptors in the failing human heart Circulation 93 1996 704 711
25. M.M. Arons, A.P. Wheeler, and G.R. Bernard Effects of ibuprofen on the physiology and survival of hypothermic sepsis. Ibuprofen in sepsis study group Crit. Care Med. 27 1999 699 707
26. S.K. Leeper-Woodford, D. Carey, and K. Byrne Histamine receptor antagonists, cyclooxygenase blockade, and tumor necrosis factor during acute septic insult Shock 9 1998 89 94
27. G.R. Bernard, A.P. Wheeler, and J.A. Russell The effects of ibuprofen on the physiology and survival of patients with sepsis. The ibuprofen in sepsis study group N. Engl. J. Med. 336 1997 912 918
28. M.T. Haupt, M.S. Jastremski, T.P. Clemmer, C.A. Metz, and G.B. Goris Effect of ibuprofen in patients with severe sepsis - a randomized, double-blind, multicenter study Crit. Care Med. 19 1991 1339 1347
29. A.N. Azab, and J. Kaplanski Involvement of eicosanoids in the hypothermic response to lipopolysaccharide during endotoxemia in rats Prostaglandin Leukot. Essent. Fatty Acids 70 2004 67 75
30. E. Abraham, K.R. Wenderin, and H. Silverman Monoclonal antibody to human necrosis factor alpha (TNFα MAb) - efficacy and safety in patients with the sepsis syndrome JAMA 273 1995 934 941
31. E. Abraham, M.P. Glauser, and T. Butler p55 tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis, and septic shock JAMA 277 1997 1531 1538
32. J. Cohen, and J. Carlet INTERSEPT - an international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor α in patients with sepsis Crit. Care Med. 24 1996 1431 1440
33. A. Matsumuri, T. Yamada, H. Suzuki, Y. Matoba, and S. Sasayama Increased circulating cytokines in patients with myocarditis and cardiomyopathy Br. Heart J. 72 1994 561 566
34. D. Li, Z. Li, and M. Liu Kinetics of tumor necrosis factor α in plasma and the cardioprotective effect of monoclonal antibody to tumor necrosis factor α in acute myocardial infarction Am. Heart. J. 137 1999 1145 1152
35. A.F. Suffredini, R.E. Fromm, and M.M. Parker The cardiovascular response of normal humans to the administration of endotoxin N. Engl. J. Med. 321 1989 280 287
36. K.J. Tracy, Y. Fong, and D.G. Hesse Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteremia Nature 330 1987 662 664
37. E. Abraham, A. Anzueto, and G. Gutierrez (NORSEPT II) Double-blind randomized controlled trial of monoclonal antibody to human tumor necrosis factor in treatment of septic shock Lancet 351 1998 929 933
38. E. Abraham, P.F. Laterre, and J. Garbino Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock - a randomized, double-blind, placebo-controlled, multicenter phase III trial with 1342 patients Crit. Care Med. 29 2001 503 510
39. A.N. Azab, and J. Kaplanski A reduction of tumor necrosis factor α in paw exudate of lipopolysaccharide treated rats by nimesulide Life Sci. 68 2001 1667 1675
40. 2 and TNF-α production by rat glial brain culture - influence of COX and cytokine inhibitors J. Endotoxin Res. 6 2001 377 381
41. R.H. Derijk, M. Van Kampen, V. Van Rooijen, and F. Berkenbosch Hypothermia to endotoxin involves reduced thermogenesis, macrophage-dependent mechanisms, and prostaglandins Am. J. Physiol. 26 1994 1 8
42. V. Fraifeld, and J. Kaplanski Brain eicosanoids and LPS fever - species and age differences Prog. Brain Res. 115 1998 141 157
43. W. Kozak, D. Soszynski, K. Rudolph, L.R. Leon, R.A. Conn, and M.J. Kluger Soluble tumor necrosis factor α receptors prevent decrease of body temperature in mice treated with indomethacin and lipopolyshaccharide Ann. NY Acad. Sci. 813 1997 264 271